The idea of a miracle cure and bodies healing themselves holds a particular fascination. Stem cell research brings regenerative medicine a step closer, but many of the ideas and concepts remain controversial. So what are stem cells, and why are they so important?
Stem cells are a type of cell that can develop into many other types of cell. Stem cells can also renew themselves by dividing, even after they have been inactive for a long time.
The human body requires many different types of cell to function, but it does not produce each cell type fully formed and ready to use. Instead, it produces stem cells that have a wide range of possible functions. However, stem cells need to become a specific cell type to be useful.
When a stem cell divides, the new cells may either become another stem cell or a specific cell, such as a blood cell, a brain cell, or a muscle cell.
Scientists call a stem cell an undifferentiated cell because it can become any cell. In contrast, a blood cell, for example, is a differentiated cell, because it is already a specific kind of cell.
In some tissues, stem cells play an essential role in regeneration, as they can divide easily to replace dead cells.
Scientists believe that knowing how stem cells work may lead to possible treatments for conditions, such as diabetes and heart disease.
For instance, if someones heart contains damaged tissue, doctors might be able to stimulate healthy tissue to grow by transplanting laboratory-grown stem cells into the persons heart. This could cause the heart tissue to renew itself.
Researchers on a small-scale study published in the Journal of Cardiovascular Translational Research tested this method.
The results showed a 40 percent reduction of the size of scarred heart tissue caused by heart attacks when doctors transplanted stem cells to the damaged area.
Doctors have always considered this kind of scarring permanent and untreatable.
However, this small study involved only 11 participants. This makes it difficult to tell whether the improvement in heart function resulted from the transplantation of stem cells or whether it was due to something else.
For example, all of the transplants took place while the individuals were undergoing heart bypass surgery, so it is possible that the improvement in heart function was due to the bypass rather than the stem cell treatment.
To investigate further, the researchers plan to do another study. This study will include a control group of people with heart failure who undergo bypass surgery but who do not receive the stem cell treatment.
Another investigation, published in Nature Communications in 2016, has suggested that stem cell therapies could be the basis of personalized diabetes treatment.
In mice and laboratory-grown cultures, researchers successfully produced insulin-secreting cells from stem cells derived from the skin of people with type 1 diabetes.
Jeffrey R. Millman, assistant professor of medicine and biomedical engineering at Washington University School of Medicine and first author, says:
In theory, if we could replace the damaged cells in these individuals with new pancreatic beta cells whose primary function is to store and release insulin to control blood glucose patients with type 1 diabetes wouldnt need insulin shots anymore.
Jeffrey R. Millman
Millman hopes that these stem cell-derived beta cells could be ready for research in humans within 3 to 5 years.
What were envisioning is an outpatient procedure in which some sort of device filled with the cells would be placed just beneath the skin, he said.
Stem cells could have vast potential in developing new therapies.
One way that scientists use stem cells at the moment is in developing and testing new drugs.
The type of stem cells that scientists commonly use for this purpose are called induced pluripotent stem cells.
These are cells that have already undergone differentiation, but which scientists have genetically reprogrammed using viruses, so they can divide and become any cell. In this way, they act like undifferentiated stem cells.
Scientists can grow differentiated cells from these pluripotent stem cells to resemble, for instance, cancer cells. Creating these cells means that scientists can use them to test anti-cancer drugs.
Researchers are already making a wide variety of cancer cells using this method. However, because they cannot yet create cells that mimic cancer cells in a controlled way, it is not always possible to replicate the results precisely.
In recent years, clinics have opened that provide stem cell treatments.
A 2016 study published in Cell Stem Cell counted 570 of these clinics in the United States alone. They offer stem cell-based therapies for disorders ranging from sports injuries to cancer.
However, stem cell therapies are still mostly theoretical rather than evidence-based.
Very few stem cell treatments have even reached the earliest phase of a clinical trial. Scientists are carrying out most of the current research in mice or a petri dish.
Despite this, the U.S. Food and Drug Administration (FDA) allow clinics to inject people with their own stem cells, as long as the cells are intended to perform only their normal function, according to Cell Stem Cell.
Scientists can harvest stem cells in different ways.
Embryonic stem cells come from an embryo that is just a few days old.
Scientists can extract adult stem cells from different types of tissue, including the brain, bone marrow, blood vessels, skeletal muscle, skin, teeth, the gut, the liver, among others.
Amniotic fluid contains stem cells. Many women opt for an amniocentesis test that checks for congenital disabilities before the child is born. If the doctor keeps the fluid, they could use it in the future to treat other conditions either during gestation or after birth.
Induced pluripotent stem cells (iPS cells) are cells that scientists can reprogram to act as stem cells, for use in regenerative medicine.
After collecting the stem cells, scientists usually store them in liquid nitrogen for future use.
Historically, the use of stem cells in medical research has been controversial.
This is because when the therapeutic use of stem cells first came to the publics attention in the late 1990s, scientists were deriving human stem cells from embryos.
Many people disagree with using human embryonic cells for medical research because extracting the stem means destroying the embryo.
This creates complex issues, as people have different beliefs about what constitutes the start of human life.
For some people, life starts when a baby is born, or when an embryo develops into a fetus. Others believe that human life begins at conception, so an embryo has the same moral status and rights as a human adult or child.
President George W. Bush had strong, pro-life religious views, and he banned funding for human stem cell research in 2001.
However, President Obamas administration allowed for a partial rolling back of these research restrictions.
However, by 2006, scientists had already started using pluripotent stem cells. Scientists do not derive these stem cells from embryonic stem cells. As a result, this technique does not have the same ethical concerns.
With this and other recent advances in stem cell technology, attitudes toward stem cell research are slowly beginning to change.
Stem cell research is helping scientists to understand how an organism develops from a single cell, and how healthy cells come to replace defective cells in people and animals.
Many severe medical conditions that occur in humans, such as cancer and congenital disabilities, happen because cells divide abnormally.
A better understanding of stem cells can provide insight into how these diseases arise and possible treatment options.
In June 2016, two researchers took second prize in the materials category of the United Kingdoms Royal Society of Chemistrys emerging technology competition for creating a synthetic biomaterial that stimulates stem cells native to a persons own teeth.
The researchers believe that this material will replace fillings, as the stem cells would prompt the damaged teeth to heal themselves.
Although much more research is necessary before stem cell therapies can become part of regular medical practice, the science around stem cells is developing all the time.
In almost every therapy area, doctors hope that stem cell technology will revolutionize therapeutic norms and introduce at least a new standard of personalized treatment, and maybe even self-healing bodies.
When that might happen, no one is quite ready to say.
Find out more here about stem cells, where they come from, and their possible uses.
- StemSynergy Therapeutics' Notch1-Selective Small Molecule Inhibitor Prevents Tumor Growth by Ablation of Cancer Stem Cells - Business Wire - April 16th, 2021
- US researchers create the first human-monkey chimaera, in the midst of a raging debate on such experimentation - The Financial Express - April 16th, 2021
- CAR T-Cell Therapy Enters the Arena in Multiple Myeloma With Ongoing Research Ahead - OncLive - April 16th, 2021
- Treating chronic myeloid leukemia (CML): By phase and more - Medical News Today - April 16th, 2021
- Cellino Biotech developing tech to help scale stem cell therapies - MedCity News - April 14th, 2021
- Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2021: Methods of Commercializing iPSCs are Diverse and Continue to Expand -... - April 14th, 2021
- A Massive New Gene Editing Project Is Out to Crush Alzheimer's - Singularity Hub - April 14th, 2021
- eQcell Inc Announces the Appointment of Members of the Board of Directors - BioSpace - April 14th, 2021
- Researchers Receive Grant to Improve Cellular Therapies to Treat 'Incurable' Diseases - University of Arkansas Newswire - April 14th, 2021
- Lonza Celebrates 20th Anniversary of Nucleofector Cell Transfection Platform - Technology Networks - April 14th, 2021
- New consortium aims to accelerate development of stem cell-based therapies for Huntingtons disease - News-Medical.Net - April 10th, 2021
- Strengthening the Stem Cell Industry Through Better Regulation - The Regulatory Review - April 10th, 2021
- Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2021: Research, Patents, Funding Events, Industry Partnerships, Biomedical... - April 10th, 2021
- Stem Cell Transplantation May Be Offered Less Often as a Treatment Option for Some Patients with Mantle Cell Lymphoma - Curetoday.com - April 10th, 2021
- Real-time imaging shines light on the coordination of neural stem cell activation - News-Medical.net - April 10th, 2021
- Searching for Molecular Targets in Myeloid Malignancies and Beyond - OncLive - April 10th, 2021
- Fitore Nutrition Launches Spectrum + to Better the Lives of Children With Autism - Influencive - April 10th, 2021
- Cancer Stem Cells Market By Size Estimation, Growth Rate, Regional Analysis With with the CAGR of 11.0% Over the Forecast Period. KSU | The Sentinel... - April 10th, 2021
- global market for regenerative medicines is predicted to grow at a CAGR of 13.99% over the forecast period of 2020-2030 - GlobeNewswire - April 10th, 2021
- Adipose Derived Stem Cell Therapy Market New Business Opportunities And Investment Research Report 2020-2027 | Coherent Market Insights KSU | The... - April 10th, 2021
- Celularity Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021 - GlobeNewswire - April 10th, 2021
- New local publication and book-signing event - Bowling Green Daily News - April 6th, 2021
- Human blastocyst-like structures generated entirely from pluripotent stem cells. Shifting the paradigm of developmental biology? - ESHRE - April 3rd, 2021
- Comprehensive Report on Stem Cell Therapy Market 2021 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Cellular Dynamics... - April 3rd, 2021
- New approach to CAR T gene therapy yields efficient and longer-lasting response against HIV - News-Medical.Net - April 3rd, 2021
- New research offers hope to women with POI - Austin Daily Herald - Austin Herald - April 3rd, 2021
- Stem Cell Therapy Market to Witness Strong Growth Over 2021-2027 | Key Manufacturers Overview- Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals,... - April 3rd, 2021
- The entelechy test: embryos and simbryos - BioNews - March 30th, 2021
- Multiple sclerosis: Recent research on causes and treatments - Medical News Today - March 30th, 2021
- Global Regenerative Medicine Conference, NCRM NICHE with Fujio Cup Quiz (FCQ), E-poster and Edogawa NICH - Times of India - March 30th, 2021
- Study: Anti-Inflammatory Therapies Could Reduce Heart Disease Risk in Elderly Patients With Clonal Hematopoiesis - Pharmacy Times - March 30th, 2021
- Can This New Electrophysiology Technology Boost Neurology Research? - Labiotech.eu - March 30th, 2021
- Stem Cell Characterization and Analysis ToolMarket Size, Share, Industry Analysis, Forecast and Global Research Report to 2027 - The Market Eagle - March 30th, 2021
- Researchers describe the systems that manage embryonic stem cells - Microbioz India - March 26th, 2021
- Cell therapy player Fate Therapeutics sees CSO and 12-year veteran Shoemaker retire - FierceBiotech - March 26th, 2021
- Stem cells - a mix of promise and hype - ABC News - March 26th, 2021
- Global Vaccine, Insulin and Stem Cell Market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis 2020-2026 The Bisouv Network... - March 26th, 2021
- Stem cell therapy could help restore debilitating age-related muscle loss - News-Medical.Net - March 24th, 2021
- Cell Culture: Disrupting the Meat Industry - Open Access Government - March 24th, 2021
- Canine Stem Cell Therapy Market Research and New Developments 2021-2026 KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper - March 24th, 2021
- Two In-Space Production Applications and Calls for Proposals Announced - Genetic Engineering & Biotechnology News - March 24th, 2021
- Hematopoietic Stem Cell Transplantation (HSCT) Market 2020-2027 Onset of Advanced Technologies to Upsurge the Growth The Courier - The Courier - March 24th, 2021
- Trending News: Stem Cell Cartilage Regeneration Market New Research Report 2021 to 2027| Anika Therapeutics, Zimmer Biomet, BioTissue Technologies -... - March 24th, 2021
- Researchers Have Grown 'Human Embryos' From Skin Cells. Is It Ethical? - The Wire Science - March 20th, 2021
- Stem cell therapy could help bear recover from painful disease - FOX 35 Orlando - March 20th, 2021
- The J&J vaccine was developed with stem cells. Thats caused confusion and division among Catholics. - OregonLive - March 20th, 2021
- Adipose-derived Stem Cell Overview Market Trend, Growth, Size, Forecast, Key Players and Competitive Landscape Research Report by2027 The Courier -... - March 20th, 2021
- Scientists Grow Tear Gland Organoids That Can Actually Cry - Freethink - March 20th, 2021
- Rheumatoid Arthritis Stem Cell Therapy Market Predicted to Witness Surge in the Near Future 2018 to 2028 KSU | The Sentinel Newspaper - KSU | The... - March 18th, 2021
- Catholic opinions on Johnson & Johnson vaccine highlight debate between hardliners on abortion and others in the church - Fairfield Citizen - March 18th, 2021
- Original Error: Retracing the History of the Mutation That Gave Rise to Cancer Decades Later - SciTechDaily - March 11th, 2021
- Super-resolution system microscopy can reveal pluripotency and differentiation of live stem cells - News-Medical.net - March 11th, 2021
- New multi-faculty Centre for Cell Therapy Translation gives UCalgary skin in the game for regenerative medicine research - UCalgary News - March 11th, 2021
- Policymakers urged to extend the 14-day limit on embryo research - BioNews - March 11th, 2021
- The Sacramento Business Journal announced that Cate Dyer, CEO, and founder of StemExpress, has been selected as one of SBJ's 2021 Most Admired CEOs -... - March 11th, 2021
- Coronavirus Insights: Ongoing Updates Covering The Impact On Induced Pluripotent Stem Cell Market - The Courier - March 11th, 2021
- Longeveron and University of Miami Expand Exclusive License Agreement, and Enter into CRADA To Facilitate Future Collaborations - GlobeNewswire - March 11th, 2021
- Adipose Stem Cells (ASCS) Market 2021 Global Analysis and Outlook: LifeCell, EMD Millipore, Geron, BrainStorm Cell Therapeutics, Minerva... - March 11th, 2021
- Human embryo research beyond the primitive streak - Science - March 5th, 2021
- Research Antibodies Market Size to Reach USD 5325.8 Million by 2027 | Increasing R&D Activities in the Fields of Oncology, Neurobiology, and Stem... - March 5th, 2021
- Stem Cell Therapy Market Research Reveals Enhanced Growth During The Forecast Period 2017 2025 FLA News - FLA News - March 5th, 2021
- Astrocytes Derived from Patients with Bipolar Disorder Malfunction - UC San Diego Health - March 5th, 2021
- Global Stem Cell Therapy Market Booming Market To Hit $ 18.66 Billion By 2027 With Top Key Players Osiris Therapeutics, Inc. (US), MEDIPOST Co., Ltd.... - March 5th, 2021
- Stem Cell Derived Exosome Production in Stirred-Tank Bioreactors - BioProcess Insider - March 5th, 2021
- Researchers study iPSCs to uncover genetic causes of disease - Drug Target Review - March 5th, 2021
- Moderna Hires Harvard Stem Cell Researcher Jonathan Hoggatt as Director of Hematology: What You Need to Know - Benzinga - March 5th, 2021
- Intrapericardial injection provides a less invasive means of treating cardiac injury - News-Medical.Net - March 5th, 2021
- Individualized brain cell grafts reverse Parkinson's symptoms in monkeys - University of Wisconsin-Madison - March 3rd, 2021
- New Controversy for Stem Cell Therapy That Repairs Spinal Cords - The Great Courses Daily News - March 3rd, 2021
- Cell Therapy Company Raises $160 Million to Advance iPSC-Derived Therapies to Clinic - BioSpace - March 3rd, 2021
- NSAIDs to Treat Arthritic Canines Through 2028; Stem Cell Therapies to Invigorate Canine Arthritis T - PharmiWeb.com - March 3rd, 2021
- A region within GLI1 gene could potentially be targeted as cancer treatment - News-Medical.Net - March 3rd, 2021
- Magenta Therapeutics Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Program Highlights - Galveston County Daily News - March 3rd, 2021
- Global Animal Stem Cell Therapy Market 2020 2025 Research Report Segment Outlook, Growth Potentials and Analysis of COVID-19 Worldwide Outbreak KSU... - March 3rd, 2021
- Global Autologous stem cell and Non-stem cell based Therapies Market- Industry Analysis, Growth, Segmentation and Forecast-2019-2027 - The Bisouv... - March 3rd, 2021
- Stem Cell manufacturing Market Witness an Outstanding Growth and Strong Revenue and Forecast 2027 KSU | The Sentinel Newspaper - KSU | The Sentinel... - March 3rd, 2021
- New study launches into COVID-19 vaccine responses in patients with impaired immune systems - University of Birmingham - March 3rd, 2021
- U. Cancer Center pilot projects: investigating cancer connections - The Brown Daily Herald - March 3rd, 2021
- Animal Stem Cell Therapy Market Size 2021 | Global Trends, Business Overview, Challenges, Opportunities and Forecast to 2027 The Bisouv Network - The... - March 1st, 2021
- Human Lung and Brain Organoids Respond Differently to SARS-CoV-2 Infection in Lab Tests - UC San Diego Health - March 1st, 2021